Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLOVNYSE:HIMS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLOVClover Health Investments$3.10-2.2%$3.45$0.90▼$4.87$1.58B1.996.64 million shs5.30 million shsHIMSHims & Hers Health$54.78-3.5%$40.77$13.47▼$72.98$12.26B1.8420.15 million shs114.55 million shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLOVClover Health Investments-2.21%-3.43%-7.19%-19.06%+164.96%HIMSHims & Hers Health-3.31%+2.61%+33.68%+33.76%+167.30%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCLOVClover Health Investments2.9092 of 5 stars3.33.00.00.03.22.50.6HIMSHims & Hers Health2.4428 of 5 stars2.02.00.00.03.13.31.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLOVClover Health Investments 2.67Moderate Buy$4.8355.91% UpsideHIMSHims & Hers Health 2.08Hold$37.67-31.25% DownsideCurrent Analyst Ratings BreakdownLatest CLOV and HIMS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/7/2025HIMSHims & Hers HealthDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold5/6/2025HIMSHims & Hers HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMixed ➝ Mixed5/6/2025HIMSHims & Hers HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$35.00 ➝ $39.005/6/2025HIMSHims & Hers HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell ➝ Sell$25.00 ➝ $30.005/6/2025HIMSHims & Hers HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$61.00 ➝ $61.004/29/2025HIMSHims & Hers HealthBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderperform ➝ Underperform$22.00 ➝ $26.004/29/2025HIMSHims & Hers HealthMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$60.00 ➝ $40.004/29/2025HIMSHims & Hers HealthTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$44.00 ➝ $30.004/25/2025HIMSHims & Hers HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSell ➝ Sell$27.00 ➝ $25.004/10/2025HIMSHims & Hers HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$39.00 ➝ $33.00(Data available from 6/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLOVClover Health Investments$1.49B1.06N/AN/A$0.59 per share5.25HIMSHims & Hers Health$1.78B6.87N/AN/A$1.61 per share34.03Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLOVClover Health Investments-$213.36M-$0.05N/AN/AN/A-5.92%-25.46%-12.35%8/4/2025 (Estimated)HIMSHims & Hers Health-$23.55M$0.69124.51105.35N/A8.19%10.97%8.29%8/4/2025 (Estimated)Latest CLOV and HIMS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2025Q1 2025CLOVClover Health Investments-$0.07$0.05+$0.12N/A$466.93 million$462.33 million5/5/2025Q1 2025HIMSHims & Hers Health$0.12$0.20+$0.08$0.20$535.21 million$586.01 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLOVClover Health InvestmentsN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLOVClover Health InvestmentsN/A1.551.55HIMSHims & Hers HealthN/A2.141.82Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLOVClover Health Investments19.77%HIMSHims & Hers Health63.52%Insider OwnershipCompanyInsider OwnershipCLOVClover Health Investments22.28%HIMSHims & Hers Health13.71%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLOVClover Health Investments680508.92 million389.46 millionOptionableHIMSHims & Hers Health650223.83 million179.79 millionOptionableCLOV and HIMS HeadlinesRecent News About These CompaniesZacks.com featured highlights EverQuote, Hims & Hers Health and Sprouts Farmers MarketJune 4 at 7:29 AM | finance.yahoo.comGAMMA Investing LLC Purchases 149,725 Shares of Hims & Hers Health, Inc. (NYSE:HIMS)June 4 at 4:31 AM | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Shares Bought by California State Teachers Retirement SystemJune 4 at 4:22 AM | marketbeat.comHims & Hers Seeks Growth in Europe as Weight-Loss Business ShiftsJune 4 at 2:27 AM | msn.comHims & Hers stock price jumps: Telehealth company acquires Zava, picking up over a million Europe customersJune 3 at 4:20 PM | fastcompany.comWhich Telehealth Stock Should You Be Targeting?June 3 at 3:22 PM | schaeffersresearch.comHims & Hers Health (NYSE:HIMS) Stock Price Down 1.1% - Should You Sell?June 3 at 2:48 PM | marketbeat.comBest Medical Stocks To Research - June 3rdJune 3 at 2:21 PM | marketbeat.comHealthcare Stocks To Add to Your Watchlist - June 3rdJune 3 at 2:21 PM | marketbeat.comHims & Hers Health, Inc. (HIMS) to Buy European Telehealth Firm as Part of Global Growth StrategyJune 3 at 12:27 PM | insidermonkey.comTop Stock Movers Now: Dollar General, Hims & Hers, Bumble, and MoreJune 3 at 12:10 PM | investopedia.comHims expands into Europe with Zava acquisitionJune 3 at 12:02 PM | youtube.comHims & Hers Health (NYSE:HIMS) Shares Gap Up - Here's What HappenedJune 3 at 11:56 AM | marketbeat.comHims & Hers Expands in Europe With Acquisition of ZAVAJune 3 at 11:25 AM | investopedia.comThe Bull Market is Back: 3 Stocks to Buy Now (HIMS, APP, META)June 3 at 11:06 AM | zacks.comWhy Hims & Hers Health, Inc. (HIMS) is a Top Momentum Stock for the Long-TermJune 3 at 10:56 AM | zacks.comHims & Hers expands into Europe with Zava acquisitionJune 3 at 10:48 AM | proactiveinvestors.comHims & Hers stock rockets on news of European launchJune 3 at 9:15 AM | finbold.comBet on Winning DuPont Analysis & Pick 3 Top StocksJune 3 at 8:46 AM | zacks.comHims to acquire UK-based startup Zava as it expands international presenceJune 3 at 7:20 AM | reuters.comHims & Hers Announces Plans to Acquire ZAVA, Accelerating Major European Growth Across the UK, Germany, France, and IrelandJune 3 at 7:15 AM | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsWill Hims & Hers Stock Be Okay After UnitedHealth's Sell-Off?By Gabriel Osorio-Mazilli | May 22, 2025View Will Hims & Hers Stock Be Okay After UnitedHealth's Sell-Off?Hims & Hers Stock Chart Points to Strong Bullish ContinuationBy Thomas Hughes | May 20, 2025View Hims & Hers Stock Chart Points to Strong Bullish ContinuationHims & Hers Stock Rises on Fundamentals and Squeeze PotentialBy Gabriel Osorio-Mazilli | May 6, 2025View Hims & Hers Stock Rises on Fundamentals and Squeeze PotentialCLOV and HIMS Company DescriptionsClover Health Investments NASDAQ:CLOV$3.10 -0.07 (-2.21%) Closing price 06/3/2025 04:00 PM EasternExtended Trading$3.14 +0.03 (+1.13%) As of 07:17 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.Hims & Hers Health NYSE:HIMS$54.78 -1.99 (-3.50%) Closing price 06/3/2025 03:59 PM EasternExtended Trading$55.58 +0.80 (+1.46%) As of 07:32 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Reasons Amazon Could Be the Best Tech Performer in June Tesla’s Lofty 200 P/E Could Mean More Upside Ollie’s Q1 Earnings: The Good, the Bad, and What’s Next Applied Digital: CoreWeave’s AI Deal Lights a $7 Billion Fuse Qualcomm: A Technical Deep-Dive Confirms the Worst Rocket Lab Expands Into Payloads: Should You Be Paying Attention? Steel Dynamics Shares Climb After Tariff Announcement Palantir Soars on Government Deals as Valuation Debate Lingers Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.